Nps Closes Placement of $155 Million of Notes
Deseret News (Salt Lake City) › December 24, 2004
Linked as:
Summary
Salt Lake-based NPS Pharmaceuticals Inc. said Thursday it has closed a private placement of $175 million of notes with institutional investors.
NPS said the notes are backed by revenues paid to NPS from sales of Sensipar, a drug licensed to and sold by Amgen.See the full content of this document
Extract
Nps Closes Placement of $155 Million of Notes
NPS also said t...
See the full content of this document
Sponsored links
